Judith Bjöhle

2.0k citations

22 papers · 1.3k indexed · 1 hit paper · h-index 14

Molecular Biology top 10%
Cancer Research top 5%
Oncology top 5%
Pulmonary and Respiratory Medicine top 10%
Radiology, Nuclear Medicine and Imaging top 10%

Co-authors: Jonas Bergh Per Hall Alexander Ploner Johanna Smeds Yudi Pawitan Sigrid Klaar Lance D. Miller Edison T. Liu
Topics: Breast Cancer Treatment Studies (15 papers)HER2/EGFR in Cancer Research (9 papers)Cancer Genomics and Diagnostics (4 papers)
Cited by: Cancer Research Oncology Radiation
Journals: Journal of Clinical Oncology JNCI Journal of the National Cancer Institute British Journal of Cancer
Partner nations: Sweden United States Singapore

In The Last Decade

Judith Bjöhle

21 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

2005 613 citations Yudi Pawitan, Judith Bjöhle et al. Breast Cancer Research profile →

Peers

Countries citing papers authored by Judith Bjöhle

Since Specialization

Citations

This map shows the geographic impact of Judith Bjöhle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Bjöhle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Bjöhle more than expected).

Fields of papers citing papers by Judith Bjöhle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Bjöhle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Bjöhle. The network helps show where Judith Bjöhle may publish in the future.

Co-authorship network of co-authors of Judith Bjöhle

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Bjöhle. A scholar is included among the top collaborators of Judith Bjöhle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Bjöhle. Judith Bjöhle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer 2024 ·JNCI Journal of the National Cancer Institute ·(unknown),Antonios Valachis,Henrik Lindman,Daniel R. Smith,(unknown),Fredrika Killander,Judith Bjöhle,(unknown),Greger Nilsson,Johan Ahlgren,Kenneth Villman	0
2	97O PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels 2020 ·Annals of Oncology ·Thomas Hatschek,Anne Andersson,Judith Bjöhle,Ana Bosch,Lena Carlsson,Ann Charlotte Dreifaldt,Zakaria Einbeigi,(unknown),Hanna Fredholm,(unknown),Mats Hellström,Hemming Johansson,Tobias Lekberg,Henrik Lindman,Ioannis Zerdes,Theodoros Foukakis,John Hartman,Yvonne Brandberg,Jonas Bergh	4
3	Docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer: Results from the Swedish PREDIX HER2 trial identifying a new potential de-escalation standard? 2019 ·Journal of Clinical Oncology ·Jonas Bergh,Anne Andersson,Judith Bjöhle,Ana Bosch,Lena Carlsson,Ann Charlotte Dreifaldt,Zakaria Einbeigi,Hanna Fredholm,(unknown),Theodoros Foukakis,(unknown),Mats Hellström,Hemming Johansson,Tobias Lekberg,Henrik Lindman,(unknown),Yvonne Brandberg,Thomas Hatschek	16
4	Post-mastectomy radiation therapy with or without implant-based reconstruction is safe in terms of clinical target volume coverage and survival – A matched cohort study 2018 ·Radiotherapy and Oncology ·Judith Bjöhle,(unknown),(unknown),Sandra Eloranta,Marie Wickman,Kerstin Sandelin,Giovanna Gagliardi,Annelie Liljegren	11
5	Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe 2018 ·European Journal of Surgical Oncology ·(unknown),Göran Liljegren,Fredrika Killander,Henrik Lindman,Judith Bjöhle,Michael Carlberg,Carl Blomqvist,Johan Ahlgren,Kenneth Villman	13
6	Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial 2017 ·International Journal of Cancer ·Siker Kimbung,(unknown),Judith Bjöhle,Tobias Lekberg,Anna von Wachenfeldt,Edward Azavedo,Ariel Saracco,Mats Hellström,Srinivas Veerla,Éric R. Paquet,Pär‐Ola Bendahl,Mårten Fernö,Jonas Bergh,Niklas Loman,Thomas Hatschek,Ingrid Hedenfalk,(unknown)	24
7	Clinical evaluation of QUANTEC guidelines to predict the risk of cardiac mortality in breast cancer patients 2016 ·Acta Oncologica ·Vitali Moiseenko,John Einck,James D. Murphy,Jakob Ödén,Judith Bjöhle,(unknown),Giovanna Gagliardi	12
8	No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction 2014 ·Radiation Oncology ·Annelie Liljegren,(unknown),Giovanna Gagliardi,Judith Bjöhle,Marie Wickman,Hemming Johansson,Kerstin Sandelin	14
9	Multi‐level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients 2014 ·Molecular Oncology ·Nicholas P. Tobin,Linda S. Lindström,Joseph W. Carlson,Judith Bjöhle,Jonas Bergh,Kristian Wennmalm	21
10	Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial 2013 ·Breast Cancer Research and Treatment ·Judith Bjöhle,Jenny Bergqvist,J. Simon Gronowitz,Hemming Johansson,Lena Carlsson,Zakaria Einbeigi,Barbro Linderholm,Niklas Loman,Martin Malmberg,Martin Söderberg,M. Sundquist,Thomas Walz,Mårten Fernö,Jonas Bergh,Thomas Hatschek	28
11	Mammographic density and molecular subtypes of breast cancer 2012 ·British Journal of Cancer ·Louise Eriksson,Per Hall,Kamila Czene,(unknown),Valerie McCormack,Jonas Bergh,Judith Bjöhle,Alexander Ploner	25
12	Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome 2007 ·Annals of Oncology ·Jenny Bergqvist,John Öhd,Johanna Smeds,Sigrid Klaar,Jorma Isola,Hans Nordgren,Göran Elmberger,Henrik Hellborg,Judith Bjöhle,Alexander Borg,Lambert Skoog,Jonas Bergh	31
13	Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen 2006 ·European Journal of Cancer ·Jenny Bergqvist,Göran Elmberger,John Öhd,Barbro Linderholm,Judith Bjöhle,Henrik Hellborg,Hans Nordgren,(unknown),Lambert Skoog,Jonas Bergh	43
14	Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients 2006 ·Breast Cancer Research ·Stefano Calza,Per Hall,Gert Auer,Judith Bjöhle,Sigrid Klaar,Ulrike Kronenwett,Edison T. Liu,Lance D. Miller,Alexander Ploner,Johanna Smeds,Jonas Bergh,Yudi Pawitan	205
15	Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes 2006 ·Genes Chromosomes and Cancer ·Kristian Wennmalm,Stefano Calza,Alexander Ploner,Per Hall,Judith Bjöhle,Sigrid Klaar,Johanna Smeds,Yudi Pawitan,Jonas Bergh	15
16	Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study 2006 ·BMC Medicine ·Per Hall,Alexander Ploner,Judith Bjöhle,Fei Huang,Chin‐Yo Lin,Edison T. Liu,Lance D. Miller,Hans Nordgren,Yudi Pawitan,Peter Shaw,Lambert Skoog,Johanna Smeds,Sara Wedrén,John Öhd,Jonas Bergh	51
17	Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohortsbreakdown → 2005 ·Breast Cancer Research ·Yudi Pawitan,Judith Bjöhle,Lukas C. Amler,(unknown),Suzanne Egyházi,Per Hall,Xia Han,Lars Holmberg,Fei Huang,Sigrid Klaar,Edison T. Liu,Lance D. Miller,Hans Nordgren,Alexander Ploner,Kerstin Sandelin,Peter Shaw,Johanna Smeds,Lambert Skoog,Sara Wedrén,Jonas Bergh	613
18	Gene profile and response to treatment 2005 ·Annals of Oncology ·Johanna Smeds,Lance D. Miller,Judith Bjöhle,Per Hall,Sigrid Klaar,(unknown),Yudi Pawitan,Alexander Ploner,Jonas Bergh	12
19	Can Axillary Dissection be Avoided by Improved Molecular Biological Diagnosis? 2000 ·Acta Oncologica ·Thomas Lindahl,Georg Engel,Johan Ahlgren,Sigrid Klaar,Judith Bjöhle,Henrik Lindman,J. Andersson,E. von Schoultz,Jonas Bergh	12
20	Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model 2000 ·International Journal of Radiation OncologyBiologyPhysics ·Giovanna Gagliardi,Judith Bjöhle,Ingmar Lax,A. Ottolenghi,Fredrik Eriksson,Anette Liedberg,Pehr Lind,Lars Erik Rutqvist	141

About Judith Bjöhle

Judith Bjöhle is a scholar working on Cancer Research, Oncology and Radiation, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (9 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (544 citations), Oncology (481 citations) and Radiation (132 citations). Judith Bjöhle has collaborated with scholars based in Sweden, United States and Singapore. Frequent co-authors include Jonas Bergh, Per Hall, Alexander Ploner, Johanna Smeds, Yudi Pawitan, Sigrid Klaar, Lance D. Miller, Edison T. Liu, Lambert Skoog and Hans Nordgren. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact